Startseite | Sitemap | Impressum | Hilfe
 
Suche:
 
 
   
DGRA INTRANET
 
   
Hier finden Sie interne Informationen für Mitglieder.
Name:
Paßwort:
Paßwort vergessen?
   
GESCHÄFTSADRESSE:
 
   
Schedestrasse 9
D-53113 Bonn

Tel.: 0228 / 368264-6
Fax: 0228 / 368264-7
E-Mail: info@dgra.de
 
DGRA-STUDIENPREIS
DGRA Studienpreisverleihung 2009 
 

Fotos von der Urkunden- und Preisverleihung, März 2010
Pressemitteilung zur Urkundenverleihung

Master-Thesis der Preisträger/-innen:

Dr. Christine Kriete
Peculiarities and Challenges of Herbal Medicinal Products - Assessment of Herbal Medicinal Products within the Regulatory Environments of the European Community and the United States

Claudia Keupp
Portfolio strategies of cytotoxic drugs – current topics of regulatory economy

Dr. Susanne Vambrie
Regulatory Requirements for the Clinical Development of New Therapies for the Treatment of Alzheimer’s Disease

Anna Paulina Paul
The Polish Pharmaceutical Law – Strenghts and Weaknesses 5 Years after Accession to the European Union. Analysis

Viola Hieble-Gerhard
Risk-based management of GMP audits within the context of supplier relationships – an approach for a medium-sized pharmaceutical company

Dr. Corinna Weidt
A regulatory guidance on achieving and maintaining proof of compliance with an agreed PIP

   
DGRA Studienpreisverleihung 2008  
 

Fotos von der Urkunden- und Preisverleihung, Februar 2009 
Pressemitteilung zur 6. Urkundenverleihung

Master-Thesis der Preisträger/-innen:

Mariela Becker
Experiences with the New Decentralised Procedure - Changes, Limits, Perspectives

Dr. Ursula Beikert
REACH - How does it affect the pharmaceutical industry? Consideration of the issue for a medium-sized enterprise

Dr. Christian Kutzleb
Comparison of the Regulatory Environment to Authorise so-called Combination Products Consisting of a Drug and a Medical Device in the US and the EU

Dr. Barbara Römer
2001/20/EC - A European Directive? Major Regulatory Objectives for a real Harmonisation in Europe

Nadine Stöckl
Optimisation of Master File Procedures for Biologics: Comparison of Master File Procedures - EU and USA

Dr. Matthias Dormeyer
Regulatory Strategies and Practical Aspects for the Development and Authorisation of Orphan Medicinal Products in the European Union

   
  DGRA Studienpreisverleihung 2007 
 

Fotos von der Urkunden- und Preisverleihung, Februar 2008 

Master-Thesis der Preisträgerinnen:

Tanja Weber (Studiengang 2004/2005)
A Step Beyond Module 3 of Biodegradable Implants

Dr. Ursula Schickel (Studiengang 2004/2005)
The impact of the revised EU-legislation concerning particular needs of blind and partially-sighted patients and user testing – a challenge for pharmaceutical companies with focus on Germany

   
  DGRA Studienpreisverleihung 2006 
 

Fotos von der Urkunden- und Preisverleihung, Februar 2007

Master-Thesis der Preisträgerinnen:

Dr. Sibylle Kaiser (Studiengang 2002/2003):
Tissue engineered products – Need and requirements for an appropriate harmonised EU regulatory framework

Dr. Astrid Weyermann (Studiengang 2004/2005):
Labelling requirements for investigational medicinal products in multinational studies: bureaucratic cost driver or added value?

Dr. Silke Jung (Studiengang 2003/2004):
New drug substances with abuse potential: Points to consider for the development and marketing

Dr. Tatyana Benicheva-Dimitrova (Studiengang 2004/2005):
Challenges For The Pharmaceutical Legislative Implementation In Terms Of An Accelerated Market Access After October 2005

   
DGRA Studienpreisverleihung 2005
 

Urkunden (PDF-Datei, 60 KB)
Foto von der Urkunden- und Preisverleihung, November 2005

Master-Thesis der Preisträger/-innen:

Dr. Arno Wiehe (Studiengang 2003/2004):
Data protection for the development of known drug substances - Changes with the review of EU legislation

Dr. Oliver Weyand (Studiengang 2003/2004):
Generic Medicinal Product Portfolio from a Regulatory and Business Development point of view

Andrea Hörner (Studiengang 2003/2004):
Describe the CADREAC-procedure for a product which was authorized via mutual recognition procedure in the EU and ...

Dr. Karen Rosenkranz (Studiengang 2002/2003):
Regulatory strategies for life-cycle management of chemical defined cytostatic drugs with regard to the new pharmaceutical legislation

Dr. Ulrike Domack (Studiengang 2002/2003):
Regulatory Science on Orphan Drug Application within Paediatric Field

   
  DGRA-Studienpreis 2004  
 

Fotos von der Preisverleihung, Juni 2004 

Master-Thesis der Preisträger/-innen:

Dr. Anja Mecklenburg (Studiengang 2001/2002):
Strategies for Carcinogenicity Testing of Human Pharmaceuticals

Dr. Michael Berntgen (Studiengang 2001/2002):
Exploring Paediatric Indications for Off-patent Drug Substances - Strategic Input of Regulatory Affairs

Birgit Moetamedi (Studiengang 2001/2002):
Comparison and assessment of the current EU-Variation Regulations 541/95 and 542/95 and the revised new EU-Variation Regulations 1084/2003 and 1085/2003

   
DGRA-Studienpreis 2002
 

Vortrag der Preisträgerin Dr. Andrea Derix:
Gewährleistung der Schutzrechte in der EU-Erweiterung (PDF-Datei, 826 KB)

Fotos von der Urkunden- und Preisverleihung, Februar 2003

   
DGRA-Studienpreis 2001
 

Pressemitteilung vom 28.11.2001:
DGRA-Studienpreis 2001 verliehen

Vortrag des Preisträgers Dr. Jürgen-Hans Schmidt:
From study protocol to final report (PDF-Datei, 95 KB)

Fotos von der Urkunden- und Preisverleihung, November 2001


 

 
nach oben drucken weiterempfehlen
 
Studium (M.D.R.A.):
Abschluß: Master of Drug
Regulatory Affairs
mehr Informationen »
DGRA-Fortbildungen:
28. Oktober 2010
Medizinprodukte

30. November 2010
e-Submission

29.-30. September 2010
8. DGRA-School | Chemisch-pharmazeutische Dokumentation

mehr Fortbildungen »
Job-Börse:
Angebot vom 29.07.2010
Senior Manager (m/f) Regulatory Affairs Pharmaceuticals CMC

Angebot vom 14.07.2010
Regulatory Affairs Manager (m/f) for the Departement RCC APAC

mehr Stellenangebote »
© 2009, DGRA e.V.
Letzte Aktualisierung am:
Mittwoch, 09.06.2010